Заражение людей вирусом оспы обезьян в 16 странах – апрель–июнь 2022 г.
Перевод научной статьи Monkeypox Virus Infection in Humans across 16 Countries – April–June 2022, July 21, 2022
DOI: 10.1056/NEJM (New England Journal of Medicine)
Перевод Г.Е. Заика
Результаты:
Таблица 4. Характеристика 32 человек с оспой обезьян в соответствии с наличием или отсутствием вирусной ДНК в семенной жидкости при ПЦР*
Симптомы, проявляющиеся следующим образом:
1, лихорадка;
2, вялость или истощение;
3, головная боль;
4, боль в горле или фарингит;
5, лимфаденопатия; и
6, миалгия.
Обсуждение
Мы описываем серию случаев оспы обезьян у людей, которая включает 528 случаев заражения из четырёх регионов ВОЗ (Европа, Северная и Южная Америка, Западная часть Тихого океана и Восточное Средиземноморье) и 16 стран, зарегистрированных за 2-месячный период. Сексуальная активность, в основном среди геев или бисексуалов, была, безусловно, наиболее часто подозреваемым путем передачи инфекции. Высокая вероятность передачи инфекции половым путем была подтверждена результатами первичных поражений слизистой оболочки гениталий, анального отверстия и полости рта, которые могут представлять место прививки. ДНК вируса оспы обезьян, которая была обнаружена методом ПЦР в семенной жидкости в 29 из 32 случаев, в которых тестировалась семенная жидкость, дополнительно подтверждает эту гипотезу. Однако, способна ли семенная жидкость передавать инфекцию ещё предстоит выяснить, так как неизвестно, является ли вирусная ДНК, обнаруживаемая в этих образцах, компетентной по репликации.
Принадлежность авторов
From the Blizard Institute and the SHARE Collaborative, Queen Mary University of London, and the Department of Infection and Immunity, Barts Health NHS Trust (J.P.T., V.A., C.M.O.), the Department of Genitourinary Medicine and Infectious Disease, Guys and St. Thomas’ NHS Trust (A.N.), the Department of Sexual Health, Homerton University Hospital (I.R.), and the Clinical Infection Unit, St. George’s University Hospitals NHS Foundation Trust (M.S.H.) — all in London; the Department of Medicine, Division of Infectious Diseases (S.B., L.B.H., M.B.K.), the J.D. MacLean Centre for Tropical Diseases (S.B.), the Research Institute of the McGill University Health Centre (S.B., M.B.K.), and the Chronic Viral Illness Service, Department of Medicine (M.B.K.), McGill University Health Centre, Montreal, and the Department of Medicine, University Health Network, University of Toronto (S.W.), the Division of Infectious Diseases and the MAP Centre for Urban Health Solutions, St. Michael’s Hospital (D.T.), and the Department of Medicine, University of Toronto (D.T.), Toronto — all in Canada; University Hospital Bonn, Department of Medicine I, Bonn (J.R., C.B.), the Department of Infectious Diseases, St. Joseph Hospital, Berlin (P.M.), Medizinisches Versorgungszentrum (MVZ) München am Goetheplatz, Munich (S. Noe), and the Infektionsmedizinisches Centrum Hamburg (ICH) Study Center, Hamburg MVZ ICH Stadmitte, Hamburg (C.H.) — all in Germany; the National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome (A.A., F.M.), the Division of Infectious Disease, Luigi Sacco Hospital, Azienda Socio-Sanitaria Territoriale Fatebenefratelli Sacco (D.M.), and the Department of Infectious and Tropical Diseases, IRCCS–Ospedale San Raffaele (S. Nozza), Milan, the Clinic of Infectious Diseases, University of Modena, Modena (C.M.), and the Infectious Diseases Division, Department of Medical Sciences, Azienda Ospedale Universita, Padua (A.C.) — all in Italy; the Department of Infectious Diseases, Sorbonne University, Assistance Publique–Hôpitaux de Paris (AP-HP), Pitié–Salpêtrière Hospital (R.P., V.P.), and the Department of Infectious Diseases, Saint Louis Lariboisière Hospital, AP-HP, University of Paris Cité (C.P.), Paris, and the Department of Prevention and Community Health, Créteil Intercommunal Hospital, Créteil (C.P.) — all in France; the HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent (L.V.), and the HIV/STI Clinic, Institute of Tropical Medicine, Antwerp (E.F.) — both in Belgium; the Sackler Faculty of Medicine, Tel Aviv University, and the Israel Department of Infectious Diseases and Infection Control, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel (M.Y.); the Department of Dermatology, University Hospital La Paz, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Investigación Hospital Universitario La Paz (E.S.), and CIBERINFEC, Instituto de Salud Carlos III (J.L.B.), Madrid, and the Infectious Diseases Service, Hospital Clinic–IDIBAPS (Instituto de Investigaciones Biomédicas August Pi i Sunyer), University of Barcelona, Barcelona (J.L.B.) – all in Spain; Hospital de Curry Cabral–Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal (F.M.M.); Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (A.G.); the Department of Infectious Diseases, University Hospital of Copenhagen, Hvidovre, Denmark (A.-B.E.H.); the Condesa Specialized Clinic, Mexico City (J.I.L.); the François-Xavier Bagnoud Center for Health and Human Rights at Harvard University, Boston (K.M.); and the Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland (J.N.).
Prof. Orkin can be contacted at c.m.orkin@qmul.ac.uk, or at the SHARE Collaborative, Centre for Immunobiology, Blizard Institute, Queen Mary University of London, 4 Newark St., London E1 2AT, United Kingdom.
The investigators in the SHARE-net clinical group are listed in the Supplementary Appendix, available at NEJM.org.
References (21)
1. Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ 1972;46:593-597. Web of Science. Medline. Google Scholar.
2. Human monkeypox – Kasai Oriental, Democratic Republic of Congo, February1996–October 1997. MMWR Morb Mortal Wkly Rep 1997;46:1168-1171. Medline. Google Scholar.
3. Durski KN, McCollum AM, Nakazawa Y, et al. Emergence of monkeypox — West and Central Africa, 1970–2017. MMWR Morb Mortal Wkly Rep 2018;67:306-310. Crossref. Medline. Google Scholar. opens in new tab
4. Vaughan A, Aarons E, Astbury J, et al. Two cases of monkeypox imported to the United Kingdom, September 2018. Euro Surveill 2018;23:1800509-1800509.Crossref. Medline. Google Scholar.
5. Vaughan A, Aarons E, Astbury J, et al. Human-to-human transmission of monkeypox virus, United Kingdom, October 2018. Emerg Infect Dis 2020;26:782-785. Web of Science. Medline. Google Scholar.
6. Erez N, Achdout H, Milrot E, et al. Diagnosis of imported monkeypox, Israel, 2018. Emerg Infect Dis 2019;25:980-983. Crossref. Medline. Google Scholar.
7. Yong SEF, Ng OT, Ho ZJM, et al. Imported monkeypox, Singapore. Emerg Infect Dis 2020;26:1826-1830. Crossref. Medline. Google Scholar.
8. Yinka-Ogunleye A, Aruna O, Dalhat M, et al. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis 2019;19:872-879. Crossref. Medline. Google Scholar.
9. Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox – a potential threat? A systematic review. PLoS Negl Trop Dis 2022;16(2): e0010141-e0010141. Crossref. Medline. Google Scholar.
10. Multi-country monkeypox outbreak: situation update. World Health Organization, June 17, 2022 (https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON 393.). Google Scholar.
11. Multi-country monkeypox outbreak: situation update. World Health Organization, June 27, 2022 ( https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON396.). Google Scholar.
12. Monkeypox: background information. UK Health Security Agency, 2018 ( ttps:// www.gov.uk/guidance/monkeypox#transmission. opens in new tab). Google Scholar.
13. Mbala PK, Huggins JW, Riu-Rovira T, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis 2017;216:824-828. Crossref. Medline. Google Scholar.
14. Monkeypox. World Health Organization, May 19, 2022 (https://www. who.int/ news-room/fact-sheets/detail/monkeypox.). Google Scholar.
15. Ogoina D, Iroezindu M, James HI, et al. Clinical course and outcome of human monkeypox in Nigeria. Clin Infect Dis 2020;71(8):e210-e214. Crossref. Medline. Google Scholar.
16. 2022 Monkeypox outbreak global map. World Health Organization, 2022 (https: //www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html.). Google Scholar.
17. O’Toole Á, Rambaut A. Initial observations about putative APOBEC3 deaminase editing driving short-term evolution of MPXV since 2017. 2022 ( https:// virological.org/t/initial-observations-about-putative-apobec3-deaminase-editing-driving-short-term-evolution-of-mpxv-since-2017/830.). Google Scholar.
18. Monkeypox: case definitions. UK Health Security Agency, 2022 ( tps:// www. gov.uk/guidance/monkeypox-case-definitions.). Google Scholar.
19. Antinori A, Mazzotta V, Vita S, et al. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Surveill 2022;27:2200421-2200421. Crossref. Medline. Google Scholar.
20. Monkeypox outbreak toolbox. World Health Organization, 2022 (https:/ www. who.int/emergencies/outbreak-toolkit/disease-outbreak-toolboxes/monkeypox-outbreak-toolbox.). Google Scholar.
21. Grosenbach DW, Honeychurch K, Rose EA, et al. Oral tecovirimat for the treatment of smallpox. N Engl J Med 2018;379:44-53. Free Full Text Medline. Google Scholar.